Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis
Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
Actinic cheilitis is a potentially malignant lesion on the lower lip, which can progress to
more serious illnesses such as cancer if not treated. Usually treatment of this condition is
only based on clinical appearance, but there is no established cure treatment. Topical
imiquimod is a medicine indicated for the treatment of skin diseases, but it has not yet been
proven to treat actinic cheilitis. In this research, the investigator's aim is to evaluate
the response to actinic cheilitis treatment with the current standard treatment compared to
high and low concentration imiquimod topical formulations.